Eli Lilly & Co
LLY· NYSE
Released Nov 2, 2023, before the open
10-Q filed Nov 2, 2023, 33 days after period end · 0000059478-23-000284
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $9.50B | $6.94B | $6.77B | $5.74B |
| Net Income | -$57.40M | $1.45B | $1.11B | $1.21B |
| EPS Diluted |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| -$0.06 |
| $1.61 |
| $1.22 |
| $1.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.